Artikler med mandater om offentlig tilgang - Andrzej PilcLes mer
Ikke tilgjengelige noe sted: 2
Where do we go next in antidepressant drug discovery? A new generation of antidepressants: A pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism
A Pilc, A Machaczka, P Kawalec, JL Smith, JM Witkin
Expert Opinion on Drug Discovery 17 (10), 1131-1146, 2022
Mandater: Narodowe Centrum Nauki
Potential use of psilocybin drugs in the treatment of depression
K Śladowska, P Kawalec, T Brzostek, A Pilc
Expert opinion on emerging drugs 28 (4), 241-256, 2023
Mandater: Narodowe Centrum Nauki
Tilgjengelige et eller annet sted: 11
Glutamate-based antidepressants: preclinical psychopharmacology
A Pilc, JM Wierońska, P Skolnick
Biological psychiatry 73 (12), 1125-1132, 2013
Mandater: US National Institutes of Health
A qualitative approach to a better understanding of the problems underlying drug shortages, as viewed from Belgian, French and the European Union’s perspectives
P Bogaert, T Bochenek, A Prokop, A Pilc
PloS one 10 (5), e0125691, 2015
Mandater: World Health Organization
Functional selectivity and antidepressant activity of serotonin 1A receptor ligands
Z Chilmonczyk, AJ Bojarski, A Pilc, I Sylte
International journal of molecular sciences 16 (8), 18474-18506, 2015
Mandater: Norges forskningsråd
The trace kynurenine, cinnabarinic acid, displays potent antipsychotic-like activity in mice and its levels are reduced in the prefrontal cortex of individuals affected by …
M Ulivieri, JM Wierońska, L Lionetto, K Martinello, P Cieslik, A Chocyk, ...
Schizophrenia Bulletin 46 (6), 1471-1481, 2020
Mandater: US National Institutes of Health, Government of Italy
Mutual activation of glutamatergic mGlu4 and muscarinic M4 receptors reverses schizophrenia-related changes in rodents
P Cieślik, M Woźniak, JM Rook, MN Tantawy, PJ Conn, F Acher, ...
Psychopharmacology 235, 2897-2913, 2018
Mandater: US National Institutes of Health
Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients
S Rzezniczek, M Obuchowicz, W Datka, M Siwek, D Dudek, K Kmiotek, ...
Translational psychiatry 6 (5), e827-e827, 2016
Mandater: US National Science Foundation, Government of Italy
Impact of biologic treatment of Crohn’s disease on the rate of surgeries and other healthcare resources: an analysis of a nationwide database from Poland
P Holko, P Kawalec, A Pilc
Frontiers in pharmacology 9, 621, 2018
Mandater: National Health and Medical Research Council, Australia
Pharmaco-Electroencephalography-Based Assessment of Antidepressant Drug Efficacy—The Use of Magnesium Ions in the Treatment of Depression
M Skalski, A Mach, P Januszko, B Ryszewska-Pokraśniewicz, ...
Journal of Clinical Medicine 10 (14), 3135, 2021
Mandater: Narodowe Centrum Nauki
The potential of scopolamine as an antidepressant in major depressive disorder: a systematic review of randomized controlled trials
P Moćko, K Śladowska, P Kawalec, Y Babii, A Pilc
Biomedicines 11 (10), 2636, 2023
Mandater: Narodowe Centrum Nauki
Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation
Y Babii, A Pałucha-Poniewiera, A Rafało-Ulińska, P Brański, A Pilc
Pharmacological Reports 76 (5), 1001-1011, 2024
Mandater: Narodowe Centrum Nauki
Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies
B Chruścicka-Smaga, A Machaczka, B Szewczyk, A Pilc
Pharmacological Reports 75 (6), 1341-1349, 2023
Mandater: Narodowe Centrum Nauki
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram